Summary:
A Randomized, Double-Blind, 24 to 52 Week Study to Assess the Safty and Efficacy of Budesonide, Glycopyrroniom, and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants with Inadiquately Controlled Asthma.
- Participants Must be at Least 12- 80 Years of Age.
- Paticipants Must be on a Stable Daily ICS/LABA Regiman for at Least 4 Weeks.
- Have a Documanted History of at Least One Asthma Exacerbation Requiring Use of Systemic Corticosteriod for 3 Days AND an Associated Physician Visit, Hospitalization, or ER Visit Due to Asthma.
Qualified Participants May Receive:
- Study Related Medication.
- Compensation For Time and Travel.
- Study Related Medical Care.